CGEMCullinan Therapeutics, Inc.

HealthcareUSD
$22.84

The financials

Cullinan Therapeutics, Inc. by the numbers

Cullinan Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$57M−$76Mn/a
Net income−$54M−$70Mn/a

Biotechnology

The closest names by size in the same industry

Compare peers
KYMR+17%
Kymera Therapeutics, Inc.
NRIX+16%
Nurix Therapeutics, Inc.
SLS+15%
SELLAS Life Sciences Group, Inc.
ZBIO+13%
Zenas BioPharma, Inc.
SLBT+12%
SL Science Holding Limited
TSHA-11%
Taysha Gene Therapies, Inc.